Preferred Label : B Acute Lymphoblastic Leukemia with UBTF-ATXN7L3/PAN3, CDX2 (CDX2/UBTF);
NCIt synonyms : B-ALL with UBTF::ATXN7L3/PAN3, CDX2 (CDX2/UBTF); B-Acute Lymphoblastic Leukemia, CDX2/UBTF-Deregulated; B Acute Lymphoblastic Leukemia, CDX2-Deregulated, UBTF::ATXN7L3 Rearranged; B-Acute Lymphoblastic Leukemia, CDX2-Deregulated, UBTF-ATXN7L3 Rearranged; B-Acute Lymphoblastic Leukemia with UBTF-ATXN7L3/PAN3, CDX2 (CDX2/UBTF); B-ALL, CDX2/UBTF-Deregulated; B-ALL, CDX2-Deregulated, UBTF-ATXN7L3 Rearranged; B-ALL with UBTF-ATXN7L3/PAN3, CDX2 (CDX2/UBTF); B-ALL, CDX2-Deregulated, UBTF::ATXN7L3 Rearranged; B Acute Lymphoblastic Leukemia, CDX2/UBTF-Deregulated; B-Acute Lymphoblastic Leukemia, CDX2-Deregulated, UBTF::ATXN7L3 Rearranged; B Acute Lymphoblastic Leukemia, CDX2-Deregulated, UBTF-ATXN7L3 Rearranged;
NCIt definition : B-acute lymphoblastic leukemia associated with concomitant CDX2 deregulation and expression
of the chimeric UBTF-ATXN7L3 fusion oncoprotein. It usually affects female adolescents
and young adults. The prognosis is poor following treatment with conventional chemotherapy.;
Neoplastic status : Malignant;
NCI Metathesaurus CUI : CL1906198;
Origin ID : C199258;
Disease excludes abnormal cell
- Disease excludes normal cell origin
- Disease may have findings
- Has associated anatomic sites
- disease_excludes_finding
- disease_has_abnormal_cell
- disease_has_finding
- disease_has_molecular_abnormality
- disease_has_normal_cell_origin
- disease_has_normal_tissue_origin
- disease_has_primary_anatomic_site
- disease_mapped_to_gene
- disease_may_have_associated_disease
- disease_may_have_molecular_abnormality
- pathogenesis_of_disease_involves_gene
